向日葵：拟购买高端半导体材料公司兮璞材料100%股权等资产 股票9月22日复牌

Group 1 - The company plans to acquire 100% equity of Zhangzhou Xipu Material Technology Co., Ltd. and 40% equity of Zhejiang Beid Pharmaceutical Co., Ltd. through a combination of share issuance and cash payment [1] - Xipu Material focuses on the research, manufacturing, and sales of high-end semiconductor materials, including high-purity electronic special gases, silicon-based precursors, and metal-based precursors, which are essential in semiconductor manufacturing processes [1] - Beid Pharmaceutical, a subsidiary of the company, specializes in the research, manufacturing, and sales of drugs for infections, cardiovascular diseases, and digestive system disorders [1] Group 2 - The company's stock is set to resume trading on September 22, 2025 [1]